Navigation Links
Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Women's Cancer
Date:3/4/2008

SOUTH SAN FRANCISCO, Calif., March 4 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a clinical-stage biopharmaceutical company developing novel anticancer therapeutics, will present data at the upcoming 39th Annual Meeting on Women's Cancer hosted by the Society of Gynecologic Oncologists (SGO). This year's conference will be held March 9-12, 2008 at the Tampa Convention Center in Tampa, Fla.

Interim data from Sunesis' ongoing Phase 2 clinical trial of SNS-595 in platinum-resistant ovarian cancer will be featured in a poster, "A Phase 2 Trial of SNS-595 in Women with Platinum-Refractory Epithelial Ovarian Cancer"(Abstract # 290), beginning on Sunday, March 9, 2008. Presenting author William P. McGuire, M.D., Medical Director of the Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital, and a lead investigator for the Phase 2 trial, will be available at the poster on Tuesday, March 11, 2008 between 2:00-3:00 p.m. to discuss the interim Phase 2 data. The poster will also be available following the conference on the Sunesis corporate website at http://www.sunesis.com.

About Sunesis' Oncology Programs

Sunesis has built a rich portfolio of product candidates in oncology focused on novel pathways and targets, including inhibition of the cell-cycle and survival signaling. The company's lead compound, SNS-595, is currently in a Phase 1b clinical trial in patients with acute leukemia and a Phase 2 clinical trial in patients with ovarian cancer. SNS-032, Sunesis' potent and selective inhibitor of cyclin-dependent kinases 2, 7 and 9, is being evaluated in a Phase 1 clinical trial in chronic lymphocytic leukemia and multiple myeloma. SN
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
2. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
5. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
6. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
7. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
8. SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results
9. NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
10. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
11. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...y on creativity, sponsored by the Jerusalem-based ...eker, revealed that a majority of the Israeli scie...al methods that could "put them into a creati...s desired." , Jerusa...ey on creativity, sponsored by the Jerusalem-based...
(Date:7/24/2008)...-FirstCall/ -- NuVasive, Inc.,(Nasdaq: NUVA ), a ...cts for,minimally disruptive surgical treatments f...d the previously announced acquisition of the Oste...Inc. (Nasdaq: OSIR ) for $35,million in cash, plu...ot to,exceed $50 million in either cash or stock, ...
(Date:7/24/2008)...nary and critical care clinicians, and resear... DURHAM, N.C., July 24 /- bioMerieux...nferences of the American Thoracic Society and,Soc...sts, pulmonary and,critical care physicians, and r...thods and technologies are needed to quickly diagn...
(Date:7/24/2008)...e/ -- Instrumentation Laboratory,(IL) today announ...ervices,company, has awarded the Company with a fi...ts and services. Broadlane, based in Dallas, TX, c...ospitals, more than 2,600,sub-acute care facilitie...contract covers IL,s portfolio of critical care an...
Breaking Biology Technology:Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3NuVasive Completes Acquisition of Osteocel Biologics Business 2NuVasive Completes Acquisition of Osteocel Biologics Business 3NuVasive Completes Acquisition of Osteocel Biologics Business 4NuVasive Completes Acquisition of Osteocel Biologics Business 5U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis 2U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis 3Instrumentation Laboratory Announces Contract for Multi-Parameter Testing Products with Broadlane 2
...s more innovation -- but how to best produce it? S...ight environment to enable inspiration and inventi...iduals to create in their own unique ways. But few...oach to creativity. Surely, many managers ask, the...uted in a consistent and repeatable manner? They b...
...Where Progress Way meets Technology Drive, "old" m...n, they decide that they really need each other. ,...n a new, 400-page analysis of the state,s manufact...xtension Manufacturing Partnership (WMEP) and pro...MPI) of Shaker Heights, Ohio. , ,The report inclu...
...rd Wave Technologies Inc. has filed suit against ...ht to sell two products, the company announced on ...Madison. , ,The company last Friday filed suit aga...ting Third Wave,s right to sell its human papillom...filed suit against Chiron Corp. , Bayer Corp., ...
...rlin, Germany plans to acquire Roentec AG, an X-...ual revenues of $6-7 million, based in Berlin. Ter...acquisition is expected to close in the fourth qua...adquarters in Madison, Wis. The worldwide X-ray mi... $150 million per year, and Bruker AXS so far has ...
Other Biology Technology:Process or practice - Choosing a path to innovation 2Process or practice - Choosing a path to innovation 3Process or practice - Choosing a path to innovation 4Whither Wisconsin manufacturing in the new global economy? 2Whither Wisconsin manufacturing in the new global economy? 3Third Wave files patent suits against Digene, Chiron and Bayer 2
(Date:7/24/2008)...m Columbia University,s Mailman School of Public H... in infant health and preventing mother-to-child H...ngs, HIV-infected mothers had been advised that fo...exclusively breast-feed, followed by a rapid weani...o the study conducted in Lusaka, Zambia by Mailman...
(Date:7/24/2008)...found a molecular link between circadian rhythms ...reveals new possibilities for the treatment of dia...lo Sassone-Corsi, Distinguished Professor and Chai...ied that an essential protein called CLOCK that re...ance with another protein called SIRT1 that modula...
(Date:7/24/2008)...ntly burning through a study area where projection... Managers used data and analysis from the Gotchen ...ing, analysis, and implementation of treatments ne...he Gotchen LSR, lies on the east slope of the Casc...cres of the Mount Adams Ranger District on the Gif...
(Date:7/23/2008)...llectively spend about $1 billion annually could p...ic tons of carbon dioxide per year for the next 25...about that much money to put an end to a tenth of ...e top contributors to greenhouse gas emissions, re...rogram could have potential to reduce global carbo...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4Breakthrough in pre eclampsia test 11643 1Breakthrough in pre eclampsia test 11643 2New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 1New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 2New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 3New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 4New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 5New Survey Suggests Confusion Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 11638 6Men who are continually active at work may have a decreased risk of prostate cancer 11636 1Men who are continually active at work may have a decreased risk of prostate cancer 11636 2Men who are continually active at work may have a decreased risk of prostate cancer 11636 3Photo 3A Animal Rescue League of Boston Receives 243 Million Grant to Establish a Center for Shelter Dogs 11631 1Photo 3A Animal Rescue League of Boston Receives 243 Million Grant to Establish a Center for Shelter Dogs 11631 2Photo 3A Animal Rescue League of Boston Receives 243 Million Grant to Establish a Center for Shelter Dogs 11631 3
... are critical to understanding the course of human...ars ago near the town of Hofmeyr, in the Eastern C...A study by an international team of scientists led...logy and Anatomical Sciences at Stony Brook Univer...ne has dated the skull to 36,000 years ago. This s...
...heights, they,re voracious, and Dr. Spencer Behmer...oak trees or on your house. , They,re post oak gr...iment Station entomologist, wants to research thei...ard of them, don,t feel alone. Until recently, mos...first 25 years of my career," said Dr. John Jackma...
... variations ensure that no two people are exactly .... Now, researchers have the tools and the knowled... cancer therapies, enabling them to create more ef...ized medicine. At the 2007 Annual Meeting of the A...rs present new biomarkers ?and techniques for dete...
...se with essential information to negotiate a burro...s presence. These stiff hairs relay sensory input ... first, studies of this system by Carnegie Mellon ...mpensate when limited to sensing the world through...Neuroscience, the results should help shape future...
Other Biology News:Hofmeyr skull supports the 'Out of Africa' theory 2Hofmeyr skull supports the 'Out of Africa' theory 3Post oak grasshoppers emerging 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 3Genes and biomarkers that allow doctors to choose the right therapy for the right patient 4Genes and biomarkers that allow doctors to choose the right therapy for the right patient 5Genes and biomarkers that allow doctors to choose the right therapy for the right patient 6Carnegie Mellon University research shows how sensory-deprived brain compensates 2
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)
Detects caspase activation by flow cytometry.
Concentration: 1mg/ml. Antigen: Propidium Iodide
Apoptosis Detection Systems and Reagents
Biology Products: